Xpert Xpress CoV-2/FLU/RSV pus
- Risk class
- III
- Product type
- In Vitro Diagnostic
- Brand name
- Xpert
- Commercial name
- 19-242.- Reagents/Kits for IVD Assays, Molecular Assay, Infection, Viruses
- Sterilization method
- METHODOLOGY: MOLECULAR BIOLOGY
- Analysis ID
- 46e8c549e6c9f06944cc74557e68ed25
- Registration date
- April 20, 2022
- Expiration date
- April 20, 2027
- Creation date
- April 20, 2022
- Name
- CEPHEID
- City
- SUNNYVALE, CA
- Country
- UNITED STATES
- Address
- 904, CARIBBEAN DRIVE -SUNNYVALE, CA 94089 - USA
- Name
- CEPHEID
- Country
- UNITED STATES
- Address
- TODOS LOS SANTOS # 201 AND AV. JORGE PEREZ CONCHA
- Phone
- 2610680
INDICATED FOR THE SIMULTANEOUS QUALITATIVE DETECTION AND DIFFERENTIATION IN VITRO OF THE RNA OF SARS-COV-2 VIRUSES, INFLUENZA A, INFLUENZA B AND RESPIRATORY SYNCYTIAL VIRUS (RSV) IN NASOPHARYNGEAL SWAB OR ANTERIOR NASAL SWAB SAMPLES COLLECTED FROM PEOPLE WITH SIGNS OR SYMPTOMS OF RESPIRATORY INFECTION OF VIRAL ORIGIN.
Access comprehensive regulatory information for Xpert Xpress CoV-2/FLU/RSV pus in the Ecuador medical device market through Pure Global AI's free database. This III medical device is registered under ARCSA ID 46e8c549e6c9f06944cc74557e68ed25 and manufactured by CEPHEID. The device was registered on April 20, 2022.
This page provides complete registration details including product type (In Vitro Diagnostic), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.